NEW YORK (GenomeWeb) – Genomic Health reported after the close of the market Tuesday that its first quarter revenues were up 6 percent year over year driven by increased sales for its Oncotype DX tests.

The Redwood City, Calif.-based molecular diagnostics firm brought in total revenues of $67 million for the three months ended March 31, up from $63.1 million in the first quarter of 2013 but below the consensus Wall Street estimate of $68.5 million. All of its revenue in the most recent quarter came from product sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.